NCT01368055View on ClinicalTrials.gov

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

361

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Prostate Cancer
Interventions
RADIATION

70 Gy/CGE

Low Risk

RADIATION

72.5 Gy/CGE

Intermediate Risk

Trial Locations (1)

32209

University of Florida Proton Therapy Institute, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER

NCT01368055 - Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer | Biotech Hunter | Biotech Hunter